Brokerages forecast that Edesa Biotech, Inc. (NASDAQ:EDSA – Get Rating) will report ($0.35) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Edesa Biotech’s earnings, with the highest EPS estimate coming in at ($0.26)…
Investors will be talking inflation again next week with the latest read on consumer prices due to arrive on June 10...
Better Therapeutics (NASDAQ:BTTX – Get Rating) and Pear Therapeutics (NASDAQ:PEAR – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, e…
According to the research report, the global digital therapeutics market size & share was valued at USD 2.18 billion in 2020 and is expected to reach
Welcome to Seeking Alpha’s Catalyst Watch - a breakdown of some of next week’s actionable events that stand out
To prepare a first class Global Prescription Digital Therapeutics (PDTx) Market research report, an
Should Health Information Services Stock Pear Therapeutics Inc (PEAR) Be in Your Portfolio Friday?
BOSTON--(BUSINESS WIRE)--Jun 2, 2022--
Digital Therapeutic Devices Industry 2022 Global Market research report is a professional and in-depth study on the market size, growth, share, trends, as
Pear Therapeutics (NASDAQ:PEAR – Get Rating) and LifeStance Health Group (NASDAQ:LFST – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, profitability, risk, earnings, analy…
Zacks Investment Research lowered shares of Pear Therapeutics from a “buy” rating to a “hold” rating in a research report on Wednesday.
Demand Analysis of Digital Therapeutics (DTx) Market Overview: “The Digital Therapeutics (DTx) Marke
Equities Research Analysts’ downgrades for Wednesday, June 1st: Angel Oak Mortgage (NYSE:AOMR) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating. The firm currently has $14.50 price target on the stock, down from their previous price target of $19.50. Cullen/Frost Bank…
The North America Digital Therapeutic (DTx) Market offers an in-depth study of the industry, packed
The report delivers the challenges in front of the Digital Therapeutics Market that allows a better
Digital Therapeutics Market: Introduction The Global Digital Therapeutics Market has seen continuous development in the past couple of years and is
The Market Insights Reports has added a new statistical market report to its repository titled as, D
The Global Neurology Digital Therapeutics Market report discusses many vital industry facets that in
Shares of Pear Therapeutics, Inc. (NASDAQ:PEAR - Get Rating) have been given an average recommendation of “Buy” by the six brokerages that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the comp
According to a recent study published by Future Market Insights, the digital therapeutics and wellness market is expected to reach US$ 26 Billion by 2032,